NTRB vs. LFWD, EYEN, RBOT, POAI, MLSS, COCH, CLGN, FBRX, BIOR, and ITRM
Should you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include ReWalk Robotics (LFWD), Eyenovia (EYEN), Vicarious Surgical (RBOT), Predictive Oncology (POAI), Milestone Scientific (MLSS), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Forte Biosciences (FBRX), Biora Therapeutics (BIOR), and Iterum Therapeutics (ITRM). These companies are all part of the "medical" sector.
Nutriband (NASDAQ:NTRB) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.
ReWalk Robotics has a net margin of -134.52% compared to Nutriband's net margin of -262.94%. ReWalk Robotics' return on equity of -33.41% beat Nutriband's return on equity.
Nutriband has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 2.06, suggesting that its share price is 106% more volatile than the S&P 500.
In the previous week, ReWalk Robotics had 11 more articles in the media than Nutriband. MarketBeat recorded 12 mentions for ReWalk Robotics and 1 mentions for Nutriband. Nutriband's average media sentiment score of 0.44 beat ReWalk Robotics' score of 0.04 indicating that Nutriband is being referred to more favorably in the media.
Nutriband has higher earnings, but lower revenue than ReWalk Robotics. Nutriband is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
Nutriband and ReWalk Robotics both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 37.50% of users gave Nutriband an outperform vote.
ReWalk Robotics has a consensus target price of $13.00, indicating a potential upside of 156.92%. Given ReWalk Robotics' higher possible upside, analysts plainly believe ReWalk Robotics is more favorable than Nutriband.
19.7% of Nutriband shares are owned by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are owned by institutional investors. 43.2% of Nutriband shares are owned by insiders. Comparatively, 2.1% of ReWalk Robotics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
ReWalk Robotics beats Nutriband on 11 of the 16 factors compared between the two stocks.
Get Nutriband News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutriband Competitors List
Related Companies and Tools
